CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation

被引:42
|
作者
Saliba, Walid [1 ,2 ,3 ]
Rennert, Gad [1 ,2 ,4 ]
机构
[1] Technion Israel Inst Technol, Clalit Hlth Serv, Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[3] Haemek Med Ctr, IL-18101 Afula, Israel
[4] Clalit Hlth Serv Headquarters, Off Chief Phys, Dept Epidemiol & Dis Prevent, Tel Aviv, Israel
来源
AMERICAN JOURNAL OF MEDICINE | 2014年 / 127卷 / 01期
关键词
Atrial fibrillation; CHA(2)DS(2)-VASc; Mortality; Pulmonary embolism; DEEP VENOUS THROMBOSIS; VEIN THROMBOSIS; SERUM 25(OH)D; THROMBOEMBOLISM; STROKE; ATHEROSCLEROSIS; GUIDELINES; MANAGEMENT; POPULATION; MORTALITY;
D O I
10.1016/j.amjmed.2013.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The risk stratification score, which includes Congestive heart failure, Hypertension, Age >= 75 [doubled], Diabetes, Stroke [doubled]-Vascular disease, Age 65-74, and Sex category [female] (CHA(2)DS(2)-VASc), is used to predict stroke in atrial fibrillation. However, whether high CHA(2)DS(2)-VASc score carries a higher risk of pulmonary embolism remains unknown. We aimed to investigate the association between the severity of CHA(2)DS(2)-VASc score and the incidence of pulmonary embolism. METHODS: A total of 73,541 adults with atrial fibrillation diagnosed before January 1, 2012, and no history of pulmonary embolism, were retrospectively identified from the computerized database of the Clalit Health Services, which is the largest not-for-profit health maintenance organization in Israel. The CHA(2)DS(2)-VASc score was calculated for each subject at study entry. The cohort was followed for the first occurrence of pulmonary embolism until December 31, 2012 (70,210 person-years). RESULTS: Pulmonary embolism developed in 158 subjects, representing an incidence of 225.0 per 100,000 person-years. The incidence of pulmonary embolism increased with increasing CHA(2)DS(2)-VASc score (P <.001). On Cox proportional analysis, CHA(2)DS(2)-VASc score was significantly associated with pulmonary embolism (hazard ratio, 1.22; 95% confidence interval [CI], 1.13-1.32) for a 1-point increase in CHA(2)DS(2)VASc score. The results were similar after adjusting for anticoagulants and antiplatelet use (hazard ratio, 1.24; 95% CI, 1.14-1.34), and remained unchanged after further adjustment for active malignancy. The predictive values for pulmonary embolism were similar for CHA(2)DS(2)-VASc score and the classic risk stratification score which includes Congestive heart failure, Hypertension, Age > 75 years, Diabetes, and Stroke [doubled] (CHADS(2)); the areas under the receiver operating characteristic curves were 0.619 (95% CI, 0.579-0.660) and 0.616 (95% CI, 0.575-0.656), respectively. CONCLUSIONS: CHA(2)DS(2)-VASc score is directly associated with the incidence of pulmonary embolism in atrial fibrillation. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [11] CHA2DS2-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer
    D'Souza, Maria
    Carlson, Nicholas
    Fosbol, Emil
    Lamberts, Morten
    Smedegaard, Laerke
    Nielsen, Dorte
    Torp-Pedersen, Christian
    Gislason, Gunnar
    Schou, Morten
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (06) : 651 - 658
  • [12] Transesophageal echocardiographic correlates of CHA2DS2-VASc score in patients with atrial fibrillation
    Mutlak, D.
    Carasso, S.
    Lessick, J.
    Aronson, D.
    Reisner, S.
    Agmon, Y.
    EUROPEAN HEART JOURNAL, 2011, 32 : 462 - 462
  • [13] Performance of the CHA2DS2-VASc score in patients with atrial fibrillation and recent cancer
    D'Souza, M.
    Carlson, N.
    Lamberts, M.
    Smedegaard, L.
    Fosboel, E. Loldrup
    Nielsen, D.
    Jakobsen, C.
    Torp-Pedersen, C.
    Gislason, G.
    Schou, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1234 - 1234
  • [14] Refinement of Ischemic Stroke Risk in Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1
    Huang, Duo
    Anguo, Luo
    Yue, Wen-Sheng
    Yin, Lixue
    Tse, Hung-Fat
    Siu, Chung-Wah
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (11): : 1442 - 1447
  • [15] How to Refine the Risk of Stroke in Atrial Fibrillation Patients with CHA2DS2-VASc Score of 1
    Li, Cho Shan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S60 - S61
  • [16] Evolution of CHA2DS2-VASc Score for Predicting Risk of Stroke Development in Patients with Atrial Fibrillation
    Rubanenko, A. O.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (02) : 197 - 202
  • [17] Changes in CHA2DS2-VASc score and risk of ischemic stroke among patients with atrial fibrillation
    Eirinaios Tsiartas
    Athanasios Samaras
    Andreas S. Papazoglou
    Anastasios Kartas
    Dimitrios V. Moysidis
    Eleftherios Gemousakakis
    Odysseas Kamzolas
    Alexandra Bekiaridou
    Ioannis Doundoulakis
    Apostolos Tzikas
    George Giannakoulas
    Heart and Vessels, 2023, 38 : 1267 - 1276
  • [18] Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score
    Yan, Shuangbing
    Li, Qing
    Xia, Zhen
    Yan, Sujuan
    Wei, Yichun
    Hong, Kui
    Wu, Yanqing
    Li, Juxiang
    Cheng, Xiaoshu
    MEDICINE, 2019, 98 (08)
  • [19] Stroke and systemic embolism risk in patients with CHA2DS2-VASc score of 0
    Babayigit, Erdi
    Mert, Gurbet Ozge
    Gorenek, Bulent
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2023, 28 (03)
  • [20] CHA2DS2-VASc score is associated with post-cardiothoracic surgery atrial fibrillation
    Baker, William L., Jr.
    Coleman, Craig I.
    White, C. Michael
    Kluger, Jeffrey
    PHARMACOTHERAPY, 2012, 32 (10): : E189 - E189